Latest News

Clinical volume surged while capacity constraints remain a watch point.

Digital PCR demand and cost cuts shaped a quarter despite academic softness.

Rentals and mortgages cushioned a sharp housing slowdown this quarter.

Operating leverage lifted adjusted EBITDA sharply, with AI gains behind it.

Record TCAD bookings and a new Tier 1 customer highlight an AI-driven pivot.

Intel's AI chip business has gained impressive momentum, and its collaboration with Oracle should help sustain this segment's impressive growth.

Sustainable business models are the key to staying alive in the commercial space race.

Management outlined how newer businesses and AI are reshaping the company's growth path.

AI adoption lifted a strong quarter and full-year outlook despite near-term costs.

Record MyPay volume and a planned Stride Bank deal are reshaping the lending story.

Suncor has undergone a major structural transformation and is well-positioned to generate strong returns across different oil price environments.

Sandisk soared as the AI revolution took off. But will competition from China bring it all crashing down?

A market rotation out of technology and into other sectors helped, and even a mediocre earnings report wasn't enough to keep Wingstop down.

Gold is down about 7% YTD and near a one-year low, presenting potential buying opportunities via IAU, AngloGold Ashanti, Gold Fields, and Alamos Gold, despite each facing distinct cost and production challenges.

These semiconductor giants are among the biggest beneficiaries of the AI chip boom, and they are expected to sustain solid growth levels over the long run.

Competition and pricing pressure weighed on sales despite strong web growth.

Income dipped as fourth-quarter fundings pick up sharply.

Cash flow reached break-even in October as the sales force builds toward its target.

These changes could affect your future benefits or your finances today.

Collegium Pharmaceutical (NASDAQ:COLL) reported record third-quarter 2026 revenue as growth in its attention-deficit/hyperactivity disorder portfolio helped offset declining sales of pain medicines. The company reaffirmed its full-year outlook, though quarterly earnings fell from a year earlier. To

Krispy Kreme (NASDAQ:DNUT) raised its 2026 revenue outlook after reporting third-quarter sales growth in its U.S. fresh delivery business and further cost reductions, though reported revenue and adjusted earnings declined as the company refranchised operations. The doughnut chain expects full-year

GPGI lowered its full-year 2026 profit and cash flow outlook as delayed cost reductions and an unfavorable product mix at Husky offset continued growth at CompoSecure (NASDAQ:CMPO), executives said on the company’s third-quarter earnings call. Executive Chairman Dave Cote said GPGI still expects to

1stdibs.com (NASDAQ:DIBS) reported higher third-quarter revenue and a return to order growth, as the online marketplace announced that Bradford Shellhammer will succeed David Rosenblatt as chief executive officer on January 1, 2027. Gross merchandise value, or GMV, rose 4% year over year to $92.6 m

Apyx Medical (NASDAQ:APYX) reported a 9% increase in third-quarter 2026 revenue, driven by sales of its AYON body contouring system in the United States and international demand for Renuvion. The company also narrowed its full-year operating expense target while reaffirming its revenue outlook. Rev

Brilliant Earth Group (NASDAQ:BRLT) reported higher third-quarter sales and a wider gross margin, but offered a measured holiday-season outlook as customers face tighter budgets for engagement rings. Net sales rose approximately 2% year over year to $112.8 million, above the company’s guidance, whi